Skip to main content
Top
Published in: Pediatric Drugs 11/2003

01-11-2003 | Therapy In Practice

Neonatal Sepsis

Epidemiology and Management

Author: Dr Robert S. Baltimore

Published in: Pediatric Drugs | Issue 11/2003

Login to get access

Abstract

Neonatal sepsis is uncommon (2–4 per 1000 live births in developed countries), but the rate increases dramatically in premature newborns and those born to mothers with infections or prolonged rupture of the fetal membranes. While infections caused by organisms contracted from the mother at birth have decreased in the past two decades, there has been an increase in nosocomial infections. Today, most infants with sepsis have been hospitalized in neonatal intensive care units for weeks or months because of extreme prematurity, or because of a congenital malformation or surgical condition. Antimicrobial therapy is usually begun prior to the isolation of a pathogen and is based upon knowledge of the likely microbes in the particular clinical situation.
The number of antimicrobial agents that can be safely used in neonates is relatively small, and dose administration usually needs to be adjusted based upon birthweight and post-gestational age. The decision whether to treat with antimicrobials should be made with consideration of the history, physical examination, and laboratory data. One should also consider the effects of the use of antimicrobials on the flora of the care unit. Bacterial resistance in the resident flora of the unit has become a major problem where there has been indiscriminate use of broad-spectrum agents.
Literature
1.
go back to reference Gladstone IM, Ehrenkranz RA, Edberg SC, et al. A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience. Pediatr Infect Dis J 1990; 9: 819–25PubMedCrossRef Gladstone IM, Ehrenkranz RA, Edberg SC, et al. A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience. Pediatr Infect Dis J 1990; 9: 819–25PubMedCrossRef
2.
go back to reference Almuneef MA, Baltimore RS, Farrel PA, et al. Molecular typing demonstrating transmission of gram-negative rods in a neonatal intensive care unit in the absence of a recognized epidemic. Clin Infect Dis 2001; 32: 221–7CrossRef Almuneef MA, Baltimore RS, Farrel PA, et al. Molecular typing demonstrating transmission of gram-negative rods in a neonatal intensive care unit in the absence of a recognized epidemic. Clin Infect Dis 2001; 32: 221–7CrossRef
3.
go back to reference Baltimore RS, Huie SM, Meek JI, et al. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics 2001; 108: 1094–8PubMedCrossRef Baltimore RS, Huie SM, Meek JI, et al. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics 2001; 108: 1094–8PubMedCrossRef
4.
go back to reference Baltimore RS. Perinatal bacterial and fungal infections. In: Jenson HB, Baltimore RS, editors. Pediatric infectious diseases: principles and practice. 2nd ed. Philadelphia (PA): WB Saunders Co., 2002: 1119–34 Baltimore RS. Perinatal bacterial and fungal infections. In: Jenson HB, Baltimore RS, editors. Pediatric infectious diseases: principles and practice. 2nd ed. Philadelphia (PA): WB Saunders Co., 2002: 1119–34
5.
go back to reference Baltimore RS. Late, late-onset infections in the nursery. Yale J Biol Med 1988; 61: 501–6PubMed Baltimore RS. Late, late-onset infections in the nursery. Yale J Biol Med 1988; 61: 501–6PubMed
6.
go back to reference Klein JO. Bacterial sepsis and meningitis. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. 5th ed. Philadelphia (PA): WB Saunders Co., 2000: 943–98 Klein JO. Bacterial sepsis and meningitis. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. 5th ed. Philadelphia (PA): WB Saunders Co., 2000: 943–98
7.
go back to reference Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: revised guidelines from the CDC. MMWR Morb Mortal Wkly Rep 2002; 51(RR11): 1–12 Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: revised guidelines from the CDC. MMWR Morb Mortal Wkly Rep 2002; 51(RR11): 1–12
8.
go back to reference Stoll BJ, Gordon T, Korones SB, et al. Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996; 129: 72–80PubMedCrossRef Stoll BJ, Gordon T, Korones SB, et al. Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996; 129: 72–80PubMedCrossRef
9.
go back to reference Cordero L, Sananes M, Ayers LW. Bloodstream infections in a neonatal intensive-care unit: 12 years’ experience with an antibacterial control program. Infect Control Hosp Epidemiol 1999; 20: 242–6PubMedCrossRef Cordero L, Sananes M, Ayers LW. Bloodstream infections in a neonatal intensive-care unit: 12 years’ experience with an antibacterial control program. Infect Control Hosp Epidemiol 1999; 20: 242–6PubMedCrossRef
10.
go back to reference Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. New Engl J Med 2000; 342: 15–20PubMedCrossRef Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. New Engl J Med 2000; 342: 15–20PubMedCrossRef
11.
go back to reference Philip AGS. The changing face of neonatal infection: experience at a regional medical center. Pediatr Infect Dis J 1994; 13: 1098–102PubMedCrossRef Philip AGS. The changing face of neonatal infection: experience at a regional medical center. Pediatr Infect Dis J 1994; 13: 1098–102PubMedCrossRef
12.
go back to reference Beck-Sague CM, Azimi P, Fonseca SN, et al. Bloodstream infections in neonatal intensive care unit patients: results of a multicenter study. Pediatr Infect Dis J 1994; 13: 1110–6PubMed Beck-Sague CM, Azimi P, Fonseca SN, et al. Bloodstream infections in neonatal intensive care unit patients: results of a multicenter study. Pediatr Infect Dis J 1994; 13: 1110–6PubMed
13.
go back to reference Stoll BJ, Gordon T, Korones SB, et al. Late-onset sepsis in very low birth weight neonates: a report for the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996; 129: 63–71PubMedCrossRef Stoll BJ, Gordon T, Korones SB, et al. Late-onset sepsis in very low birth weight neonates: a report for the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996; 129: 63–71PubMedCrossRef
14.
go back to reference Gaynes RP, Edwards JR, Jarvis WR, et al. Nosocomial infections among neonates in high-risk nurseries in the United States. National Nosocomial Infections Surveillance System. Pediatrics 1996; 98: 357–61PubMed Gaynes RP, Edwards JR, Jarvis WR, et al. Nosocomial infections among neonates in high-risk nurseries in the United States. National Nosocomial Infections Surveillance System. Pediatrics 1996; 98: 357–61PubMed
15.
go back to reference Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 1976; 294: 753–6PubMedCrossRef Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 1976; 294: 753–6PubMedCrossRef
16.
go back to reference Edwards MS, Baker CJ. Group B streptococcal infections. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. 5th ed. Philadelphia (PA): WB Saunders Co., 2000: 1091–156 Edwards MS, Baker CJ. Group B streptococcal infections. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. 5th ed. Philadelphia (PA): WB Saunders Co., 2000: 1091–156
17.
go back to reference Manroe BL, Weinberg AG, Rosenfeld CR, et al. The neonatal blood count in health and disease (1): reference values for neutrophilic cells. J Pediatr 1979; 95: 89–98PubMedCrossRef Manroe BL, Weinberg AG, Rosenfeld CR, et al. The neonatal blood count in health and disease (1): reference values for neutrophilic cells. J Pediatr 1979; 95: 89–98PubMedCrossRef
18.
go back to reference Enguix A, Rey C, Concha A, et al. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intensive Care Med 2001; 27: 211–5PubMedCrossRef Enguix A, Rey C, Concha A, et al. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intensive Care Med 2001; 27: 211–5PubMedCrossRef
19.
go back to reference Hatherill M, Tibby SM, Sykes K, et al. Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leucocyte count. Arch Dis Child 1999; 81: 417–21PubMedCrossRef Hatherill M, Tibby SM, Sykes K, et al. Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leucocyte count. Arch Dis Child 1999; 81: 417–21PubMedCrossRef
20.
go back to reference Gendrel D, Assicot M, Raymond J, et al. Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr 1996; 128: 570–3PubMedCrossRef Gendrel D, Assicot M, Raymond J, et al. Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr 1996; 128: 570–3PubMedCrossRef
21.
go back to reference Gendrel D, Raymond J, Coste J, et al. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs viral infections. Pediatr Infect Dis J 1999; 18: 875–81PubMedCrossRef Gendrel D, Raymond J, Coste J, et al. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs viral infections. Pediatr Infect Dis J 1999; 18: 875–81PubMedCrossRef
22.
go back to reference Gendrel D, Bohuon C. Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis J 2000; 19(8): 679–87PubMedCrossRef Gendrel D, Bohuon C. Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis J 2000; 19(8): 679–87PubMedCrossRef
23.
go back to reference Mehr S, Doyle LW. Cytokines as markers of bacterial sepsis in newborn infants: a review. Pediatr Infect Dis J 2000; 19: 879–87PubMedCrossRef Mehr S, Doyle LW. Cytokines as markers of bacterial sepsis in newborn infants: a review. Pediatr Infect Dis J 2000; 19: 879–87PubMedCrossRef
24.
go back to reference Ng PC, Cheng SH, Chui KM, et al. Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants. Arch Dis Child 1997; 77: F221–7CrossRef Ng PC, Cheng SH, Chui KM, et al. Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants. Arch Dis Child 1997; 77: F221–7CrossRef
25.
go back to reference Doellner H, Arntzen KJ, Haereid PE, et al. Interleukin-6 concentrations in neonates evaluated for sepsis. J Pediatr 1998; 132: 295–9PubMedCrossRef Doellner H, Arntzen KJ, Haereid PE, et al. Interleukin-6 concentrations in neonates evaluated for sepsis. J Pediatr 1998; 132: 295–9PubMedCrossRef
26.
go back to reference Franz AR, Steinbach G, Kron M, et al. Reduction of unnecessary antibiotic therapy in newborn infants using interleukin-8 and C-reactive protein as markers of bacterial infections. Pediatrics 1999; 104: 447–53PubMedCrossRef Franz AR, Steinbach G, Kron M, et al. Reduction of unnecessary antibiotic therapy in newborn infants using interleukin-8 and C-reactive protein as markers of bacterial infections. Pediatrics 1999; 104: 447–53PubMedCrossRef
27.
go back to reference Weirich E, Rabin RL, Maldonado Y, et al. Neutrophil CD11b expression as a diagnostic marker for early-onset neonatal infection. J Pediatr 1998; 132: 445–51PubMedCrossRef Weirich E, Rabin RL, Maldonado Y, et al. Neutrophil CD11b expression as a diagnostic marker for early-onset neonatal infection. J Pediatr 1998; 132: 445–51PubMedCrossRef
28.
go back to reference Ehl S, Gering B, Bartmann P, et al. C-reactive protein is a useful marker for guiding duration of antibiotic therapy in suspected neonatal bacterial infection. Pediatrics 1997; 99: 216–21PubMedCrossRef Ehl S, Gering B, Bartmann P, et al. C-reactive protein is a useful marker for guiding duration of antibiotic therapy in suspected neonatal bacterial infection. Pediatrics 1997; 99: 216–21PubMedCrossRef
29.
go back to reference Philip AGS, Hewitt JR. Early diagnosis of neonatal sepsis. Pediatrics 1980; 65: 1036–41PubMed Philip AGS, Hewitt JR. Early diagnosis of neonatal sepsis. Pediatrics 1980; 65: 1036–41PubMed
30.
go back to reference Philip AGS. Decreased use of antibiotics using a neonatal screening technique. J Pediatr 1981; 98: 795–9PubMedCrossRef Philip AGS. Decreased use of antibiotics using a neonatal screening technique. J Pediatr 1981; 98: 795–9PubMedCrossRef
31.
go back to reference Schwersenski J, McIntyre L, Bauer CR. Lumbar puncture frequency and cerebrospinal fluid analysis in the neonate. Am J Dis Child 1991; 145: 54–8PubMed Schwersenski J, McIntyre L, Bauer CR. Lumbar puncture frequency and cerebrospinal fluid analysis in the neonate. Am J Dis Child 1991; 145: 54–8PubMed
32.
go back to reference Fonseca SNS, Ehrenkranz RA, Baltimore RS. Epidemiology of antibiotic use in a neonatal intensive care unit. Infect Control Hosp Epidemiol 1994; 15: 156–62PubMedCrossRef Fonseca SNS, Ehrenkranz RA, Baltimore RS. Epidemiology of antibiotic use in a neonatal intensive care unit. Infect Control Hosp Epidemiol 1994; 15: 156–62PubMedCrossRef
33.
go back to reference Young TE, Mangum B. Neofax®: a manual of drugs used in neonatal care. 15th ed. Raleigh (NC): Acorn Publishing, 2002 Young TE, Mangum B. Neofax®: a manual of drugs used in neonatal care. 15th ed. Raleigh (NC): Acorn Publishing, 2002
34.
go back to reference Nelson JD, Bradley JS. 2000–2001 Nelson’s pocket book of pediatric antimicrobial therapy. 14th ed. Philadelphia (PA): Lippincott Williams and Wilkins, 2000 Nelson JD, Bradley JS. 2000–2001 Nelson’s pocket book of pediatric antimicrobial therapy. 14th ed. Philadelphia (PA): Lippincott Williams and Wilkins, 2000
35.
go back to reference The medical letter on drugs and therapeutics: handbook of antimicrobial therapy. 16th ed. New York: The Medical Letter, 2002 The medical letter on drugs and therapeutics: handbook of antimicrobial therapy. 16th ed. New York: The Medical Letter, 2002
36.
go back to reference Bryan CS, John Jr JF, Pai S, et al. Gentamicin vs cefotaxime for therapy of neonatal sepsis: relationship to drug resistance. Am J Dis Child 1985; 139: 1086–9PubMed Bryan CS, John Jr JF, Pai S, et al. Gentamicin vs cefotaxime for therapy of neonatal sepsis: relationship to drug resistance. Am J Dis Child 1985; 139: 1086–9PubMed
37.
go back to reference De Man P, Verhoeven BAN, Verbrugh HA, et al. An antibiotic policy to prevent emergence of resistant bacilli. Lancet 2000; 355: 973–8PubMedCrossRef De Man P, Verhoeven BAN, Verbrugh HA, et al. An antibiotic policy to prevent emergence of resistant bacilli. Lancet 2000; 355: 973–8PubMedCrossRef
38.
go back to reference Reed MD, Blumer JL. Anti-infective therapy. In: Jenson HB, Baltimore RS, editors. Pediatric infectious diseases: principles and practice. 2nd ed. Philadelphia (PA): WB Saunders Co, 2002: 147–215 Reed MD, Blumer JL. Anti-infective therapy. In: Jenson HB, Baltimore RS, editors. Pediatric infectious diseases: principles and practice. 2nd ed. Philadelphia (PA): WB Saunders Co, 2002: 147–215
39.
go back to reference Vitale R, Baltimore RS. Pediatric aminoglycoside dosing guidelines. New Haven (CT): Yale-New Haven Hospital, 2002 Vitale R, Baltimore RS. Pediatric aminoglycoside dosing guidelines. New Haven (CT): Yale-New Haven Hospital, 2002
40.
go back to reference Cairo MS, Worcester CC, Rucker RW, et al. Randomized trial of granulocyte transfusion versus immune globulin therapy for neonatal neutropenia and sepsis. J Pediatr 1992; 120: 281–5PubMedCrossRef Cairo MS, Worcester CC, Rucker RW, et al. Randomized trial of granulocyte transfusion versus immune globulin therapy for neonatal neutropenia and sepsis. J Pediatr 1992; 120: 281–5PubMedCrossRef
41.
go back to reference Miura E, Procianoy RS, Bittar C, et al. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis. Pediatrics 2001; 107: 30–5PubMedCrossRef Miura E, Procianoy RS, Bittar C, et al. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis. Pediatrics 2001; 107: 30–5PubMedCrossRef
42.
go back to reference Bilgin K, Yaramis A, Haspolat K, et al. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia. Pediatrics 2001; 107: 36–41PubMedCrossRef Bilgin K, Yaramis A, Haspolat K, et al. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia. Pediatrics 2001; 107: 36–41PubMedCrossRef
43.
go back to reference Bernstein HM, Calhoun DA, Christensen RD. Use of myeloid colony-stimulating factors in neonates with septicemia. Curr Opin Pediatr 2002; 14: 91–4PubMedCrossRef Bernstein HM, Calhoun DA, Christensen RD. Use of myeloid colony-stimulating factors in neonates with septicemia. Curr Opin Pediatr 2002; 14: 91–4PubMedCrossRef
44.
go back to reference Berger M. Use of intravenously administered immune globulin in newborn infants: prophylaxis, treatment, both, or neither? J Pediatr 1991; 118: 557–9PubMedCrossRef Berger M. Use of intravenously administered immune globulin in newborn infants: prophylaxis, treatment, both, or neither? J Pediatr 1991; 118: 557–9PubMedCrossRef
45.
go back to reference Jenson HB, Pollock BH. Meta-analyses of the effectiveness of intravenous immune globulin for the prevention and treatment of neonatal sepsis. Pediatrics 1997; 99(2): E2PubMedCrossRef Jenson HB, Pollock BH. Meta-analyses of the effectiveness of intravenous immune globulin for the prevention and treatment of neonatal sepsis. Pediatrics 1997; 99(2): E2PubMedCrossRef
46.
go back to reference Giroir BP. Recombinant human activated protein C for the treatment of severe sepsis: is there a role in pediatrics? Curr Opin Pediatr 2003; 15: 92–6PubMedCrossRef Giroir BP. Recombinant human activated protein C for the treatment of severe sepsis: is there a role in pediatrics? Curr Opin Pediatr 2003; 15: 92–6PubMedCrossRef
47.
go back to reference Van den Anker JN, van Popele NML, Sauer PJJ. Antifungal agents in neonatal systemic candidiasis. Antimicrob Agents Chemother 1995; 39: 1391–7PubMedCrossRef Van den Anker JN, van Popele NML, Sauer PJJ. Antifungal agents in neonatal systemic candidiasis. Antimicrob Agents Chemother 1995; 39: 1391–7PubMedCrossRef
48.
go back to reference Sanchez PJ, Siegel JD, Fishein J. Candida endocarditis: successful medical management in three preterm infants and review of the literature. Pediatr Infect Dis J 1991; 10: 239–43PubMedCrossRef Sanchez PJ, Siegel JD, Fishein J. Candida endocarditis: successful medical management in three preterm infants and review of the literature. Pediatr Infect Dis J 1991; 10: 239–43PubMedCrossRef
49.
go back to reference Butler KM, Rench MA, Baker CJ. Amphotericin B as a single agent in the treatment of systemic candidiasis in neonates. Pediatr Infect Dis J 1990; 9: 51–6PubMedCrossRef Butler KM, Rench MA, Baker CJ. Amphotericin B as a single agent in the treatment of systemic candidiasis in neonates. Pediatr Infect Dis J 1990; 9: 51–6PubMedCrossRef
Metadata
Title
Neonatal Sepsis
Epidemiology and Management
Author
Dr Robert S. Baltimore
Publication date
01-11-2003
Publisher
Springer International Publishing
Published in
Pediatric Drugs / Issue 11/2003
Print ISSN: 1174-5878
Electronic ISSN: 1179-2019
DOI
https://doi.org/10.2165/00148581-200305110-00002

Other articles of this Issue 11/2003

Pediatric Drugs 11/2003 Go to the issue